0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Biologics Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-16R8119
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and China Veterinary Biologics Market Insights Forecast to 2027
BUY CHAPTERS

Global Veterinary Biologics Market Research Report 2025

Code: QYRE-Auto-16R8119
Report
July 2025
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Biologics Market Size

The global market for Veterinary Biologics was valued at US$ 12260 million in the year 2024 and is projected to reach a revised size of US$ 19430 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Veterinary Biologics Market

Veterinary Biologics Market

Veterinary biologics are vaccines, antigens, antitoxins and other preparations made from living organisms (or genetically engineered) and intended for use in diagnosing, treating, or immunizing animals. Unlike some pharmaceutical products, such as antibiotics, most biologics leave no residues in animals.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Biologics.
The Veterinary Biologics market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary Biologics Market Report

Report Metric Details
Report Name Veterinary Biologics Market
Accounted market size in year US$ 12260 million
Forecasted market size in 2031 US$ 19430 million
CAGR 6.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Llivestock
  • Equine
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco/Eli Lilly, Virbac, Jinyu Bio-Technology, ChengDu Tecbond, CAVAC, Kyoto Biken, FATRO, Vaksindo, Bio-Labs, Avimex Animal
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Veterinary Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Veterinary Biologics Market growing?

Ans: The Veterinary Biologics Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Veterinary Biologics Market size in 2031?

Ans: The Veterinary Biologics Market size in 2031 will be US$ 19430 million.

Who are the main players in the Veterinary Biologics Market report?

Ans: The main players in the Veterinary Biologics Market are Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco/Eli Lilly, Virbac, Jinyu Bio-Technology, ChengDu Tecbond, CAVAC, Kyoto Biken, FATRO, Vaksindo, Bio-Labs, Avimex Animal

What are the Application segmentation covered in the Veterinary Biologics Market report?

Ans: The Applications covered in the Veterinary Biologics Market report are Llivestock, Equine, Other

What are the Type segmentation covered in the Veterinary Biologics Market report?

Ans: The Types covered in the Veterinary Biologics Market report are Vaccines, Monoclonal Antibodies

Recommended Reports

Veterinary Biologics

Biologic Drug Development

Veterinary Diagnostics

1 Veterinary Biologics Market Overview
1.1 Product Definition
1.2 Veterinary Biologics by Type
1.2.1 Global Veterinary Biologics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vaccines
1.2.3 Monoclonal Antibodies
1.3 Veterinary Biologics by Application
1.3.1 Global Veterinary Biologics Market Value by Application (2024 VS 2031)
1.3.2 Llivestock
1.3.3 Equine
1.3.4 Other
1.4 Global Veterinary Biologics Market Size Estimates and Forecasts
1.4.1 Global Veterinary Biologics Revenue 2020-2031
1.4.2 Global Veterinary Biologics Sales 2020-2031
1.4.3 Global Veterinary Biologics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Veterinary Biologics Market Competition by Manufacturers
2.1 Global Veterinary Biologics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Veterinary Biologics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Veterinary Biologics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Veterinary Biologics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Biologics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Biologics, Product Type & Application
2.7 Global Key Manufacturers of Veterinary Biologics, Date of Enter into This Industry
2.8 Global Veterinary Biologics Market Competitive Situation and Trends
2.8.1 Global Veterinary Biologics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Veterinary Biologics Players Market Share by Revenue
2.8.3 Global Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Biologics Market Scenario by Region
3.1 Global Veterinary Biologics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Veterinary Biologics Sales by Region: 2020-2031
3.2.1 Global Veterinary Biologics Sales by Region: 2020-2025
3.2.2 Global Veterinary Biologics Sales by Region: 2026-2031
3.3 Global Veterinary Biologics Revenue by Region: 2020-2031
3.3.1 Global Veterinary Biologics Revenue by Region: 2020-2025
3.3.2 Global Veterinary Biologics Revenue by Region: 2026-2031
3.4 North America Veterinary Biologics Market Facts & Figures by Country
3.4.1 North America Veterinary Biologics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Veterinary Biologics Sales by Country (2020-2031)
3.4.3 North America Veterinary Biologics Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Biologics Market Facts & Figures by Country
3.5.1 Europe Veterinary Biologics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Veterinary Biologics Sales by Country (2020-2031)
3.5.3 Europe Veterinary Biologics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Biologics Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Biologics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Veterinary Biologics Sales by Region (2020-2031)
3.6.3 Asia Pacific Veterinary Biologics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Veterinary Biologics Market Facts & Figures by Country
3.7.1 Latin America Veterinary Biologics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Veterinary Biologics Sales by Country (2020-2031)
3.7.3 Latin America Veterinary Biologics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Biologics Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Biologics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Veterinary Biologics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Veterinary Biologics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Biologics Sales by Type (2020-2031)
4.1.1 Global Veterinary Biologics Sales by Type (2020-2025)
4.1.2 Global Veterinary Biologics Sales by Type (2026-2031)
4.1.3 Global Veterinary Biologics Sales Market Share by Type (2020-2031)
4.2 Global Veterinary Biologics Revenue by Type (2020-2031)
4.2.1 Global Veterinary Biologics Revenue by Type (2020-2025)
4.2.2 Global Veterinary Biologics Revenue by Type (2026-2031)
4.2.3 Global Veterinary Biologics Revenue Market Share by Type (2020-2031)
4.3 Global Veterinary Biologics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Veterinary Biologics Sales by Application (2020-2031)
5.1.1 Global Veterinary Biologics Sales by Application (2020-2025)
5.1.2 Global Veterinary Biologics Sales by Application (2026-2031)
5.1.3 Global Veterinary Biologics Sales Market Share by Application (2020-2031)
5.2 Global Veterinary Biologics Revenue by Application (2020-2031)
5.2.1 Global Veterinary Biologics Revenue by Application (2020-2025)
5.2.2 Global Veterinary Biologics Revenue by Application (2026-2031)
5.2.3 Global Veterinary Biologics Revenue Market Share by Application (2020-2031)
5.3 Global Veterinary Biologics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Veterinary Biologics Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Company Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zoetis Veterinary Biologics Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Veterinary Biologics Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Company Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ceva Veterinary Biologics Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Company Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CAHIC Veterinary Biologics Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 HVRI
6.6.1 HVRI Company Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 HVRI Veterinary Biologics Product Portfolio
6.6.5 HVRI Recent Developments/Updates
6.7 Ringpu Biology
6.7.1 Ringpu Biology Company Information
6.7.2 Ringpu Biology Description and Business Overview
6.7.3 Ringpu Biology Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ringpu Biology Veterinary Biologics Product Portfolio
6.7.5 Ringpu Biology Recent Developments/Updates
6.8 Yebio
6.8.1 Yebio Company Information
6.8.2 Yebio Description and Business Overview
6.8.3 Yebio Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Yebio Veterinary Biologics Product Portfolio
6.8.5 Yebio Recent Developments/Updates
6.9 DHN
6.9.1 DHN Company Information
6.9.2 DHN Description and Business Overview
6.9.3 DHN Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 DHN Veterinary Biologics Product Portfolio
6.9.5 DHN Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Company Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 WINSUN Veterinary Biologics Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Elanco/Eli Lilly
6.11.1 Elanco/Eli Lilly Company Information
6.11.2 Elanco/Eli Lilly Description and Business Overview
6.11.3 Elanco/Eli Lilly Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Elanco/Eli Lilly Veterinary Biologics Product Portfolio
6.11.5 Elanco/Eli Lilly Recent Developments/Updates
6.12 Virbac
6.12.1 Virbac Company Information
6.12.2 Virbac Description and Business Overview
6.12.3 Virbac Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Virbac Veterinary Biologics Product Portfolio
6.12.5 Virbac Recent Developments/Updates
6.13 Jinyu Bio-Technology
6.13.1 Jinyu Bio-Technology Company Information
6.13.2 Jinyu Bio-Technology Description and Business Overview
6.13.3 Jinyu Bio-Technology Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Jinyu Bio-Technology Veterinary Biologics Product Portfolio
6.13.5 Jinyu Bio-Technology Recent Developments/Updates
6.14 ChengDu Tecbond
6.14.1 ChengDu Tecbond Company Information
6.14.2 ChengDu Tecbond Description and Business Overview
6.14.3 ChengDu Tecbond Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.14.4 ChengDu Tecbond Veterinary Biologics Product Portfolio
6.14.5 ChengDu Tecbond Recent Developments/Updates
6.15 CAVAC
6.15.1 CAVAC Company Information
6.15.2 CAVAC Description and Business Overview
6.15.3 CAVAC Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.15.4 CAVAC Veterinary Biologics Product Portfolio
6.15.5 CAVAC Recent Developments/Updates
6.16 Kyoto Biken
6.16.1 Kyoto Biken Company Information
6.16.2 Kyoto Biken Description and Business Overview
6.16.3 Kyoto Biken Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Kyoto Biken Veterinary Biologics Product Portfolio
6.16.5 Kyoto Biken Recent Developments/Updates
6.17 FATRO
6.17.1 FATRO Company Information
6.17.2 FATRO Description and Business Overview
6.17.3 FATRO Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.17.4 FATRO Veterinary Biologics Product Portfolio
6.17.5 FATRO Recent Developments/Updates
6.18 Vaksindo
6.18.1 Vaksindo Company Information
6.18.2 Vaksindo Description and Business Overview
6.18.3 Vaksindo Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Vaksindo Veterinary Biologics Product Portfolio
6.18.5 Vaksindo Recent Developments/Updates
6.19 Bio-Labs
6.19.1 Bio-Labs Company Information
6.19.2 Bio-Labs Description and Business Overview
6.19.3 Bio-Labs Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Bio-Labs Veterinary Biologics Product Portfolio
6.19.5 Bio-Labs Recent Developments/Updates
6.20 Avimex Animal
6.20.1 Avimex Animal Company Information
6.20.2 Avimex Animal Description and Business Overview
6.20.3 Avimex Animal Veterinary Biologics Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Avimex Animal Veterinary Biologics Product Portfolio
6.20.5 Avimex Animal Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Biologics Industry Chain Analysis
7.2 Veterinary Biologics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Biologics Production Mode & Process Analysis
7.4 Veterinary Biologics Sales and Marketing
7.4.1 Veterinary Biologics Sales Channels
7.4.2 Veterinary Biologics Distributors
7.5 Veterinary Biologics Customer Analysis
8 Veterinary Biologics Market Dynamics
8.1 Veterinary Biologics Industry Trends
8.2 Veterinary Biologics Market Drivers
8.3 Veterinary Biologics Market Challenges
8.4 Veterinary Biologics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Veterinary Biologics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Veterinary Biologics Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Veterinary Biologics Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Veterinary Biologics Sales (M Units) of Key Manufacturers (2020-2025)
 Table 5. Global Veterinary Biologics Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Veterinary Biologics Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Veterinary Biologics Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Veterinary Biologics Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Veterinary Biologics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Veterinary Biologics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Veterinary Biologics, Product Type & Application
 Table 12. Global Key Manufacturers of Veterinary Biologics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Veterinary Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Biologics as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Veterinary Biologics Sales by Region (2020-2025) & (M Units)
 Table 18. Global Veterinary Biologics Sales Market Share by Region (2020-2025)
 Table 19. Global Veterinary Biologics Sales by Region (2026-2031) & (M Units)
 Table 20. Global Veterinary Biologics Sales Market Share by Region (2026-2031)
 Table 21. Global Veterinary Biologics Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Veterinary Biologics Revenue Market Share by Region (2020-2025)
 Table 23. Global Veterinary Biologics Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Veterinary Biologics Revenue Market Share by Region (2026-2031)
 Table 25. North America Veterinary Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Veterinary Biologics Sales by Country (2020-2025) & (M Units)
 Table 27. North America Veterinary Biologics Sales by Country (2026-2031) & (M Units)
 Table 28. North America Veterinary Biologics Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Veterinary Biologics Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Veterinary Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Veterinary Biologics Sales by Country (2020-2025) & (M Units)
 Table 32. Europe Veterinary Biologics Sales by Country (2026-2031) & (M Units)
 Table 33. Europe Veterinary Biologics Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Veterinary Biologics Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Veterinary Biologics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Veterinary Biologics Sales by Region (2020-2025) & (M Units)
 Table 37. Asia Pacific Veterinary Biologics Sales by Region (2026-2031) & (M Units)
 Table 38. Asia Pacific Veterinary Biologics Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Veterinary Biologics Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Veterinary Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Veterinary Biologics Sales by Country (2020-2025) & (M Units)
 Table 42. Latin America Veterinary Biologics Sales by Country (2026-2031) & (M Units)
 Table 43. Latin America Veterinary Biologics Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Veterinary Biologics Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Veterinary Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Veterinary Biologics Sales by Country (2020-2025) & (M Units)
 Table 47. Middle East and Africa Veterinary Biologics Sales by Country (2026-2031) & (M Units)
 Table 48. Middle East and Africa Veterinary Biologics Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Veterinary Biologics Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Veterinary Biologics Sales (M Units) by Type (2020-2025)
 Table 51. Global Veterinary Biologics Sales (M Units) by Type (2026-2031)
 Table 52. Global Veterinary Biologics Sales Market Share by Type (2020-2025)
 Table 53. Global Veterinary Biologics Sales Market Share by Type (2026-2031)
 Table 54. Global Veterinary Biologics Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Veterinary Biologics Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Veterinary Biologics Revenue Market Share by Type (2020-2025)
 Table 57. Global Veterinary Biologics Revenue Market Share by Type (2026-2031)
 Table 58. Global Veterinary Biologics Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Veterinary Biologics Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Veterinary Biologics Sales (M Units) by Application (2020-2025)
 Table 61. Global Veterinary Biologics Sales (M Units) by Application (2026-2031)
 Table 62. Global Veterinary Biologics Sales Market Share by Application (2020-2025)
 Table 63. Global Veterinary Biologics Sales Market Share by Application (2026-2031)
 Table 64. Global Veterinary Biologics Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Veterinary Biologics Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Veterinary Biologics Revenue Market Share by Application (2020-2025)
 Table 67. Global Veterinary Biologics Revenue Market Share by Application (2026-2031)
 Table 68. Global Veterinary Biologics Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Veterinary Biologics Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Veterinary Biologics Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Zoetis Company Information
 Table 76. Zoetis Description and Business Overview
 Table 77. Zoetis Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Zoetis Veterinary Biologics Product
 Table 79. Zoetis Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim Veterinary Biologics Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Ceva Company Information
 Table 86. Ceva Description and Business Overview
 Table 87. Ceva Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ceva Veterinary Biologics Product
 Table 89. Ceva Recent Developments/Updates
 Table 90. CAHIC Company Information
 Table 91. CAHIC Description and Business Overview
 Table 92. CAHIC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. CAHIC Veterinary Biologics Product
 Table 94. CAHIC Recent Developments/Updates
 Table 95. HVRI Company Information
 Table 96. HVRI Description and Business Overview
 Table 97. HVRI Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. HVRI Veterinary Biologics Product
 Table 99. HVRI Recent Developments/Updates
 Table 100. Ringpu Biology Company Information
 Table 101. Ringpu Biology Description and Business Overview
 Table 102. Ringpu Biology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Ringpu Biology Veterinary Biologics Product
 Table 104. Ringpu Biology Recent Developments/Updates
 Table 105. Yebio Company Information
 Table 106. Yebio Description and Business Overview
 Table 107. Yebio Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Yebio Veterinary Biologics Product
 Table 109. Yebio Recent Developments/Updates
 Table 110. DHN Company Information
 Table 111. DHN Description and Business Overview
 Table 112. DHN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. DHN Veterinary Biologics Product
 Table 114. DHN Recent Developments/Updates
 Table 115. WINSUN Company Information
 Table 116. WINSUN Description and Business Overview
 Table 117. WINSUN Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. WINSUN Veterinary Biologics Product
 Table 119. WINSUN Recent Developments/Updates
 Table 120. Elanco/Eli Lilly Company Information
 Table 121. Elanco/Eli Lilly Description and Business Overview
 Table 122. Elanco/Eli Lilly Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Elanco/Eli Lilly Veterinary Biologics Product
 Table 124. Elanco/Eli Lilly Recent Developments/Updates
 Table 125. Virbac Company Information
 Table 126. Virbac Description and Business Overview
 Table 127. Virbac Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Virbac Veterinary Biologics Product
 Table 129. Virbac Recent Developments/Updates
 Table 130. Jinyu Bio-Technology Company Information
 Table 131. Jinyu Bio-Technology Description and Business Overview
 Table 132. Jinyu Bio-Technology Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Jinyu Bio-Technology Veterinary Biologics Product
 Table 134. Jinyu Bio-Technology Recent Developments/Updates
 Table 135. ChengDu Tecbond Company Information
 Table 136. ChengDu Tecbond Description and Business Overview
 Table 137. ChengDu Tecbond Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. ChengDu Tecbond Veterinary Biologics Product
 Table 139. ChengDu Tecbond Recent Developments/Updates
 Table 140. CAVAC Company Information
 Table 141. CAVAC Description and Business Overview
 Table 142. CAVAC Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. CAVAC Veterinary Biologics Product
 Table 144. CAVAC Recent Developments/Updates
 Table 145. Kyoto Biken Company Information
 Table 146. Kyoto Biken Description and Business Overview
 Table 147. Kyoto Biken Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Kyoto Biken Veterinary Biologics Product
 Table 149. Kyoto Biken Recent Developments/Updates
 Table 150. FATRO Company Information
 Table 151. FATRO Description and Business Overview
 Table 152. FATRO Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. FATRO Veterinary Biologics Product
 Table 154. FATRO Recent Developments/Updates
 Table 155. Vaksindo Company Information
 Table 156. Vaksindo Description and Business Overview
 Table 157. Vaksindo Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Vaksindo Veterinary Biologics Product
 Table 159. Vaksindo Recent Developments/Updates
 Table 160. Bio-Labs Company Information
 Table 161. Bio-Labs Description and Business Overview
 Table 162. Bio-Labs Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Bio-Labs Veterinary Biologics Product
 Table 164. Bio-Labs Recent Developments/Updates
 Table 165. Avimex Animal Company Information
 Table 166. Avimex Animal Description and Business Overview
 Table 167. Avimex Animal Veterinary Biologics Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Avimex Animal Veterinary Biologics Product
 Table 169. Avimex Animal Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Veterinary Biologics Distributors List
 Table 173. Veterinary Biologics Customers List
 Table 174. Veterinary Biologics Market Trends
 Table 175. Veterinary Biologics Market Drivers
 Table 176. Veterinary Biologics Market Challenges
 Table 177. Veterinary Biologics Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary Biologics
 Figure 2. Global Veterinary Biologics Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Veterinary Biologics Market Share by Type: 2024 & 2031
 Figure 4. Vaccines Product Picture
 Figure 5. Monoclonal Antibodies Product Picture
 Figure 6. Global Veterinary Biologics Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Veterinary Biologics Market Share by Application: 2024 & 2031
 Figure 8. Llivestock
 Figure 9. Equine
 Figure 10. Other
 Figure 11. Global Veterinary Biologics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Veterinary Biologics Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Veterinary Biologics Sales (2020-2031) & (M Units)
 Figure 14. Global Veterinary Biologics Average Price (US$/Unit) & (2020-2031)
 Figure 15. Veterinary Biologics Report Years Considered
 Figure 16. Veterinary Biologics Sales Share by Manufacturers in 2024
 Figure 17. Global Veterinary Biologics Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Veterinary Biologics Players: Market Share by Revenue in Veterinary Biologics in 2024
 Figure 19. Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Veterinary Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Veterinary Biologics Sales Market Share by Country (2020-2031)
 Figure 22. North America Veterinary Biologics Revenue Market Share by Country (2020-2031)
 Figure 23. United States Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Veterinary Biologics Sales Market Share by Country (2020-2031)
 Figure 26. Europe Veterinary Biologics Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Veterinary Biologics Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Veterinary Biologics Revenue Market Share by Region (2020-2031)
 Figure 34. China Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Veterinary Biologics Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Veterinary Biologics Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Veterinary Biologics Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Veterinary Biologics Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Veterinary Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Veterinary Biologics by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Veterinary Biologics by Type (2020-2031)
 Figure 55. Global Veterinary Biologics Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Veterinary Biologics by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Veterinary Biologics by Application (2020-2031)
 Figure 58. Global Veterinary Biologics Price (US$/Unit) by Application (2020-2031)
 Figure 59. Veterinary Biologics Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart